about
Vibro-acoustography imaging of permanent prostate brachytherapy seeds in an excised human prostate--preliminary results and technical feasibility.Magnetic resonance imaging compatible robotic system for fully automated brachytherapy seed placement.Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor rangeDiffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancerProstatome: a combined anatomical and disease based MRI atlas of the prostate.Preliminary Evaluation of a MRI-compatible Modular Robotic System for MRI-guided Prostate InterventionsDevelopment of a Pneumatic Robot for MRI-guided Transperineal Prostate Biopsy and Brachytherapy: New Approaches.Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer.Automatic brachytherapy seed placement under MRI guidance.Avoidance and management of positive surgical margins before, during and after radical prostatectomy.The use of early postoperative prostate-specific antigen to stratify risk in patients with positive surgical margins after radical prostatectomy.The next generation of positron emission tomography radiopharmaceuticals in oncology.An MRI-compatible robotic system with hybrid tracking for MRI-guided prostate interventionDesign of a novel MRI compatible manipulator for image guided prostate interventions.Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner.System for MR image-guided prostate interventions: canine studyRobotic system for MRI-guided prostate biopsy: feasibility of teleoperated needle insertion and ex vivo phantom study.Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 Tesla endorectal, in vivo T2-weighted MR imagery.Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy.Three-dimensional sonography with needle tracking: role in diagnosis and treatment of prostate cancerClass-specific weighting for Markov random field estimation: application to medical image segmentation.Development and Evaluation of an Actuated MRI-Compatible Robotic System for MRI-Guided Prostate Intervention.Robotic prostate surgery.System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner.MRI-guided HDR prostate brachytherapy in standard 1.5T scanner.Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI.A workspace-orientated needle-guiding robot for 3T MRI-guided transperineal prostate intervention: evaluation of in-bore workspace and MRI compatibility.Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical OverviewAccuracy study of a robotic system for MRI-guided prostate needle placementMolecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET.A hierarchical spectral clustering and nonlinear dimensionality reduction scheme for detection of prostate cancer from magnetic resonance spectroscopy (MRS).The role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: the Beth Israel Deaconess Medical Center (BIDMC) approachA biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatment.Imaging in prostate cancer staging: present role and future perspectives.Functional magnetic resonance imaging and molecular pathology at the crossroad of the management of early prostate cancer.MR Imaging of Prostate Cancer: Diffusion Weighted Imaging and (3D) Hydrogen 1 (H) MR Spectroscopy in Comparison with Histology.Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts.Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer.PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer.Multiparametric MRI for prostate cancer detection: performance in patients with prostate-specific antigen values between 2.5 and 10 ng/mL.
P2860
Q30483065-8879C4E4-08AC-4054-AD77-C128587185A6Q30500387-0B721980-6C5A-4137-A67B-924D5E9BC98EQ31042719-CA341B33-9A32-495F-AB46-D82404F65E4CQ33464875-4E100FFD-AFD6-44B4-9F7A-4AB904AB562CQ34296620-BBCC058F-8069-47A0-9E3E-2694EDE5AB75Q34373028-77F08606-35F4-47F7-AA79-C122537BB041Q34635197-E6306108-9CFC-4F28-8560-23E391BD708AQ34918676-38561EA2-47D2-4FF9-BDBD-2454B2B7459BQ34997252-9E78D527-65CC-4D66-AED4-634F61FE70A8Q35081740-A79B0392-5076-4325-AC2E-536927656393Q35296487-00F0F054-BAE2-45DA-9BCC-17412F481896Q35525690-1F03BD50-0E28-42F5-805D-71663D7331DBQ35821982-5597D755-3DD4-4393-8049-453AE01E711BQ35821991-E9F701AD-6857-4B5A-895A-9AB52D2D758EQ35822135-118BA6C6-5935-44D5-8D1D-356711D1D2B3Q35825791-08900428-ED9D-47F7-9259-A047C9A7F5A9Q35972817-6D98D133-3FE5-4EFC-B6A1-A797812B2D3DQ36004153-CA4C36AD-3310-4BFB-81FC-59846898F96DQ36010923-98E9D2B5-2029-4ED9-B36A-720910A342A0Q36110346-9C930FEB-C31F-4D3A-B5B1-69D2C40AE976Q36429125-EC11F73E-9F18-4890-BFA1-8E1E09DC3E90Q36529675-E4C86CF5-34FE-4EF0-85F8-FB37ADCE9F71Q36634296-399C4B4A-225E-4156-80CE-E8F0696E8ED4Q36676031-C1B82514-7557-47AD-99A3-7859406BF0B7Q36676285-5C18F845-D70E-461F-8051-6A83A0B8EF59Q36792155-1DFF2892-81F2-456F-BB2F-431BDA5D984AQ36908395-B191596C-0E30-48D4-AC10-12CA2B759397Q36979944-91E6B6B3-885E-4111-B336-32EFFB8A1C0CQ37170437-D84C6C31-FBA4-4925-8B3F-C6DD2DE2AE70Q37325974-DA97EFC4-04BB-461F-8564-667D6DCFBAE9Q37335007-5850F45A-F2BA-43D3-982A-EB3A344677CFQ37337735-B2FE5976-76E8-4A89-A722-C9B748D9D1A6Q37476975-4FEF37A5-3097-4438-A6BF-F8E2A4A1E435Q37979650-82F577CB-4F08-4439-B83F-71EDD8398CC0Q38461592-0F43B799-2E34-4238-8A28-1490A716FBC4Q38782559-C4C435B7-F618-417B-8FC5-55DEB726615EQ39571686-94235599-20F3-46D7-8202-1530230979DFQ39998299-FA02AD8A-CB2B-436B-8FC3-E23B807DE4BDQ40036038-8207AAFC-925E-4CE0-8060-3811AB765088Q40206375-BC1443D8-B8C0-4C0B-A8A9-7512C24BE293
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Imaging prostate cancer.
@ast
Imaging prostate cancer.
@en
type
label
Imaging prostate cancer.
@ast
Imaging prostate cancer.
@en
prefLabel
Imaging prostate cancer.
@ast
Imaging prostate cancer.
@en
P1476
Imaging prostate cancer.
@en
P304
59-85, viii
P356
10.1016/S0033-8389(05)70150-0
P577
2000-01-01T00:00:00Z